Search research articles
Contact Us
Filters
Showing results (41-50 of 47) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 47 results.
Frontiers in Immunology
|
May 31, 2024
Targeted complement inhibition using bispecific antibodies that bind local antigens and endogenous complement regulators
Haiyu Wang, Fleur S van de Bovenkamp, Douwe J Dijkstra, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 4, 2023
Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation
Douwe J Dijkstra, Fleur S van de Bovenkamp, Leoni Abendstein, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 28, 2020
Endothelial and Inflammation Biomarker Profiles at Diagnosis Reflecting Clinical Heterogeneity and Serving as a Prognostic Tool for Treatment Response in Two Independent Cohorts of Patients With Juvenile Dermatomyositis
Judith Wienke, Lauren M Pachman, Gabrielle A Morgan, et al.
Journal for Immunotherapy of Cancer
|
June 30, 2024
Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma
Jessica S W Borgers, Tineke J van Wesemael, Kyra A Gelderman, et al.
Molecular Immunology
|
March 18, 2020
Expression and production of the SERPING1-encoded endogenous complement regulator C1-inhibitor in multiple cohorts of tuberculosis patients
Rosalie Lubbers, Jayne S Sutherland, Delia Goletti, et al.
Frontiers in Immunology
|
November 9, 2018
Complement Component C1q as Serum Biomarker to Detect Active Tuberculosis
Rosalie Lubbers, Jayne S Sutherland, Delia Goletti, et al.
The Journal of Allergy and Clinical Immunology
|
January 30, 2023
Differences in IgG autoantibody Fab glycosylation across autoimmune diseases
Jana Koers, Rocco Sciarrillo, Ninotska I L Derksen, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 47) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 47 results.
Frontiers in Immunology
|
May 31, 2024
Targeted complement inhibition using bispecific antibodies that bind local antigens and endogenous complement regulators
Haiyu Wang, Fleur S van de Bovenkamp, Douwe J Dijkstra, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 4, 2023
Human anti-C1q autoantibodies bind specifically to solid-phase C1q and enhance phagocytosis but not complement activation
Douwe J Dijkstra, Fleur S van de Bovenkamp, Leoni Abendstein, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 28, 2020
Endothelial and Inflammation Biomarker Profiles at Diagnosis Reflecting Clinical Heterogeneity and Serving as a Prognostic Tool for Treatment Response in Two Independent Cohorts of Patients With Juvenile Dermatomyositis
Judith Wienke, Lauren M Pachman, Gabrielle A Morgan, et al.
Journal for Immunotherapy of Cancer
|
June 30, 2024
Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma
Jessica S W Borgers, Tineke J van Wesemael, Kyra A Gelderman, et al.
Molecular Immunology
|
March 18, 2020
Expression and production of the SERPING1-encoded endogenous complement regulator C1-inhibitor in multiple cohorts of tuberculosis patients
Rosalie Lubbers, Jayne S Sutherland, Delia Goletti, et al.
Frontiers in Immunology
|
November 9, 2018
Complement Component C1q as Serum Biomarker to Detect Active Tuberculosis
Rosalie Lubbers, Jayne S Sutherland, Delia Goletti, et al.
The Journal of Allergy and Clinical Immunology
|
January 30, 2023
Differences in IgG autoantibody Fab glycosylation across autoimmune diseases
Jana Koers, Rocco Sciarrillo, Ninotska I L Derksen, et al.
Page
of 5